2w3 min read
Medical Article
Introduction Triple-negative breast cancer (TNBC) remains one of the most aggressive subtypes of breast cancer, characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 expression (1). It represents 15–20% of breast cancers and is associated with aggressive behaviour, high recu

Phase III Evaluation of Carboplatin-Augmented Sequential Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Similar Content

Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1008 Reached2 Comments

Treatment of Recurrent Adult Medulloblastoma
2602 Reached1 Comments4 Likes

Black Lesion in Old Female
1974 Reached5 Comments11 Likes

NSCLC Treatment To Control Long-term Tumor Growth
216 Reached1 Comments

Secondary Pseudophakic Malignant Glaucoma
1622 Reached21 Comments12 Likes
